Using Psychedelics to Treat Postpartum Depression

Despite affecting one in seven women (and one in 10 men) postpartum depression (PPD) is still somewhat of an enigma. There are no treatment options for it (despite affecting 1 in 7 women (and 1 in 10 men)). In fact, the FDA approved the first ever drug for PPD (Zulresso) in 2019, which costs $7450 per vial (about $34,000 per patient without insurance). Fortunately, new hope has arrived for 17% of the global population that is impacted by PPD as well as children, partners, and entire families who experience harm. As it turns out, psychedelics may be used to treat postpartour depression as both treatment and preventative.